Share on StockTwits

Novartis AG (NYSE:NVS) released its earnings data on Thursday. The company reported $1.36 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.36, American Banking & Market News reports.

Several analysts have recently commented on the stock. Analysts at Barclays upgraded shares of Novartis AG from an “underweight” rating to an “equal weight” rating in a research note on Monday, June 9th. On the ratings front, analysts at Leerink Swann raised their price target on shares of Novartis AG from $93.00 to $104.00 in a research note on Wednesday, May 28th. They now have an “outperform” rating on the stock. Finally, analysts at Jefferies Group upgraded shares of Novartis AG from a “hold” rating to a “buy” rating in a research note on Friday, May 2nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $93.50.

Novartis AG (NYSE:NVS) opened at 90.04 on Thursday. Novartis AG has a 52-week low of $70.95 and a 52-week high of $91.66. The stock has a 50-day moving average of $90.02 and a 200-day moving average of $85.00. The company has a market cap of $220.3 billion and a price-to-earnings ratio of 22.99.

Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.